266 related articles for article (PubMed ID: 34222745)
21. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
22. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
23. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.
Woldaregay AZ; Årsand E; Walderhaug S; Albers D; Mamykina L; Botsis T; Hartvigsen G
Artif Intell Med; 2019 Jul; 98():109-134. PubMed ID: 31383477
[TBL] [Abstract][Full Text] [Related]
24. Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays.
Rubio-Viqueira B; Mezzadra H; Nielsen ME; Jimeno A; Zhang X; Iacobuzio-Donahue C; Maitra A; Hidalgo M; Altiok S
Mol Cancer Ther; 2007 Feb; 6(2):515-23. PubMed ID: 17308050
[TBL] [Abstract][Full Text] [Related]
25. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
26. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
27. Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.
Roelants C; Pillet C; Franquet Q; Sarrazin C; Peilleron N; Giacosa S; Guyon L; Fontanell A; Fiard G; Long JA; Descotes JL; Cochet C; Filhol O
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963500
[TBL] [Abstract][Full Text] [Related]
28. The emergence of drug resistance to targeted cancer therapies: Clinical evidence.
Sarmento-Ribeiro AB; Scorilas A; Gonçalves AC; Efferth T; Trougakos IP
Drug Resist Updat; 2019 Dec; 47():100646. PubMed ID: 31733611
[TBL] [Abstract][Full Text] [Related]
29. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
30. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
31. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
Santiago-Delefosse M; Cahen F; Coeffin-Driol C
Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
[TBL] [Abstract][Full Text] [Related]
32. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
[TBL] [Abstract][Full Text] [Related]
33. Reproducing the human mucosal environment ex vivo: inflammatory bowel disease as a paradigm.
Swanson KD; Theodorou E; Kokkotou E
Curr Opin Gastroenterol; 2018 Nov; 34(6):384-391. PubMed ID: 30188406
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(5):1-47. PubMed ID: 23074408
[TBL] [Abstract][Full Text] [Related]
35. On the Way to New Horizons: Telemedicine in Oncology.
Schlag PM
Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
[TBL] [Abstract][Full Text] [Related]
36. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
Poste G
Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
[TBL] [Abstract][Full Text] [Related]
38. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
39. Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment.
Scott CL; Becker MA; Haluska P; Samimi G
Front Oncol; 2013 Dec; 3():295. PubMed ID: 24363999
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
